A patient undergoing chemotherapy develops severe aplastic anemia. Which mechanism explains why erythropoietin (EPO) treatment is unlikely to resolve the anemia effectively?

💡 Explanation

In aplastic anemia, the bone marrow's hematopoietic stem cells are severely damaged or destroyed, because this prevents the production of new red blood cells, including those responsive to erythropoietin. Therefore, EPO treatment is ineffective, rather than downregulation or antibody-mediated destruction being the primary issue.

• Why does excessive platelet aggregation increase stroke risk in atherosclerosis?
• Why does hypokalemia (low potassium) in nervous tissue impair signal transmission?
• Why does a decrease in the ventilation-perfusion ratio (V/Q) increase hypoxemia more severely than a similar increase decreases hypercapnia?
• If a person's sebum production decreases substantially while living in a cold, dry climate, which consequence follows regarding skin integrity?
• A patient with pulmonary fibrosis has thickened alveolar membranes. Which mechanism explains why their blood oxygen saturation decreases even with supplemental oxygen?
• If a hiker's core body temperature drops significantly in cold conditions, which consequence follows regarding thermoregulation?